Ibne Karim M. Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ibne Karim M. Ali has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Shantanu Roy
Waterborne Disease Prevention Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention Atlanta, Georgia, USA
4 shared publicationsJennifer R. Cope
Waterborne Disease Prevention Branch, DFWED/NCEZID, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
3 shared publicationsAlyssa Kelley
Eagle Medical Services, Atlanta, Georgia, USA
2 shared publications- Antoinette Cassiopeia Russell
University of Georgia, Department of Infectious Diseases
2 shared publications - Dennis E. Kyle
Center for Tropical and Emerging Global Diseases, University of Georgia
2 shared publications - Jose Alexander
AdventHealth Central Florida, Microbiology Department
2 shared publications
Latest Publications
- Open Access
- 14 July 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 14
Secreted small RNAs of Naegleria fowleri are biomarkers for diagnosis of primary amoebic meningoencephalitis
Rapid and accurate diagnostics are needed to effectively detect and treat primary amoebic meningoencephalitis (PAM) caused by the free-living amoeba, Naegleria fowleri. Delayed diagnosis and similarities to other causes of meningitis contribute to a case mortality rate of >97%, and current testing requires a spinal tap to obtain cerebrospinal fluid (CSF). Thus, there is an unmet medical need for a non-invasive liquid biopsy diagnostic method. We sequenced N. fowleri extracellular vesicles (EVs) and identified microRNAs, tRNAs and other small RNAs in N. fowleri-EVs. From these data we selected two prevalent small RNAs as biomarker candidates. We developed an RT-qPCR assay and both small RNAs were detected in N. fowleri-EVs and amoeba-conditioned media. In the mouse model of PAM, both small RNA biomarkers were detected in 100% of mouse plasma samples at the end-stage of infection. Notably, smallRNA-1 was detected in the urine of infected mice at timepoints as early as 24h post infection (18/23 mice) and in the plasma as early as 60h post infection (8/8 mice). Additionally, smallRNA-1 was detected in 100% (n=6) of CSF samples from human PAM cases, and in whole blood samples, but not in human plasma from PAM cases. In this study, we discovered small RNAs as biomarkers of N. fowleri infection—one which can be detected reliably in CSF, urine, and whole blood. The RT-qPCR assay is a highly sensitive diagnostic assay that can be conducted in ∼3h after receipt of liquid biopsy. The data suggest detection of smallRNA-1 biomarker could provide earlier diagnosis of PAM and be used to monitor biomass of amoebae during treatment.
- 14 July 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 14
Open AccessSecreted small RNAs of Naegleria fowleri are biomarkers for diagnosis of primary amoebic meningoencephalitis
Rapid and accurate diagnostics are needed to effectively detect and treat primary amoebic meningoencephalitis (PAM) caused by the free-living amoeba, Naegleria fowleri. Delayed diagnosis and similarities to other causes of meningitis contribute to a case mortality rate of >97%, and current testing requires a spinal tap to obtain cerebrospinal fluid (CSF). Thus, there is an unmet medical need for a non-invasive liquid biopsy diagnostic method. We sequenced N. fowleri extracellular vesicles (EVs) and identified microRNAs, tRNAs and other small RNAs in N. fowleri-EVs. From these data we selected two prevalent small RNAs as biomarker candidates. We developed an RT-qPCR assay and both small RNAs were detected in N. fowleri-EVs and amoeba-conditioned media. In the mouse model of PAM, both small RNA biomarkers were detected in 100% of mouse plasma samples at the end-stage of infection. Notably, smallRNA-1 was detected in the urine of infected mice at timepoints as early as 24h post infection (18/23 mice) and in the plasma as early as 60h post infection (8/8 mice). Additionally, smallRNA-1 was detected in 100% (n=6) of CSF samples from human PAM cases, and in whole blood samples, but not in human plasma from PAM cases. In this study, we discovered small RNAs as biomarkers of N. fowleri infection—one which can be detected reliably in CSF, urine, and whole blood. The RT-qPCR assay is a highly sensitive diagnostic assay that can be conducted in ∼3h after receipt of liquid biopsy. The data suggest detection of smallRNA-1 biomarker could provide earlier diagnosis of PAM and be used to monitor biomass of amoebae during treatment.
- Open Access
Secreted small RNAs of Naegleria fowleri are biomarkers for diagnosis of primary amoebic meningoencephalitis
Rapid and accurate diagnostics are needed to effectively detect and treat primary amoebic meningoencephalitis (PAM) caused by the free-living amoeba, Naegleria fowleri . Delayed diagnosis and similarities to other causes of meningitis contribute to a case mortality rate of >97%, and current testing requires a spinal tap to obtain cerebrospinal fluid (CSF). Thus, there is an unmet medical need for a non-invasive liquid biopsy diagnostic method. We sequenced N. fowleri extracellular vesicles (EVs) and identified microRNAs, tRNAs and other small RNAs in N. fowleri- EVs. From these data we selected two prevalent small RNAs as biomarker candidates. We developed an RT-qPCR assay and both small RNAs were detected in N. fowleri- EVs and amoeba-conditioned media. In the mouse model of PAM, both small RNA biomarkers were detected in 100% of mouse plasma samples at the end-stage of infection. Notably, smallRNA-1 was detected in the urine of infected mice at timepoints as early as 24h post infection (18/23 mice) and in the plasma as early as 60h post infection (8/8 mice). Additionally, smallRNA-1 was detected in 100% (n=6) of CSF samples from human PAM cases, and in whole blood samples, but not in human plasma from PAM cases. In this study, we discovered small RNAs as biomarkers of N. fowleri infection—one which can be detected reliably in CSF, urine, and whole blood. The RT-qPCR assay is a highly sensitive diagnostic assay that can be conducted in ∼3h after receipt of liquid biopsy. The data suggest detection of smallRNA-1 biomarker could provide earlier diagnosis of PAM and be used to monitor biomass of amoebae during treatment. One Sentence Summary: Small RNAs of Naegleria fowleri can be detected in liquid biopsies and serve as early diagnostic biomarkers of primary amoebic meningoencephalitis.
Open AccessSecreted small RNAs of Naegleria fowleri are biomarkers for diagnosis of primary amoebic meningoencephalitis
Rapid and accurate diagnostics are needed to effectively detect and treat primary amoebic meningoencephalitis (PAM) caused by the free-living amoeba, Naegleria fowleri . Delayed diagnosis and similarities to other causes of meningitis contribute to a case mortality rate of >97%, and current testing requires a spinal tap to obtain cerebrospinal fluid (CSF). Thus, there is an unmet medical need for a non-invasive liquid biopsy diagnostic method. We sequenced N. fowleri extracellular vesicles (EVs) and identified microRNAs, tRNAs and other small RNAs in N. fowleri- EVs. From these data we selected two prevalent small RNAs as biomarker candidates. We developed an RT-qPCR assay and both small RNAs were detected in N. fowleri- EVs and amoeba-conditioned media. In the mouse model of PAM, both small RNA biomarkers were detected in 100% of mouse plasma samples at the end-stage of infection. Notably, smallRNA-1 was detected in the urine of infected mice at timepoints as early as 24h post infection (18/23 mice) and in the plasma as early as 60h post infection (8/8 mice). Additionally, smallRNA-1 was detected in 100% (n=6) of CSF samples from human PAM cases, and in whole blood samples, but not in human plasma from PAM cases. In this study, we discovered small RNAs as biomarkers of N. fowleri infection—one which can be detected reliably in CSF, urine, and whole blood. The RT-qPCR assay is a highly sensitive diagnostic assay that can be conducted in ∼3h after receipt of liquid biopsy. The data suggest detection of smallRNA-1 biomarker could provide earlier diagnosis of PAM and be used to monitor biomass of amoebae during treatment. One Sentence Summary: Small RNAs of Naegleria fowleri can be detected in liquid biopsies and serve as early diagnostic biomarkers of primary amoebic meningoencephalitis.
- 13 November 2023
- Published by Taylor & Francis
- p. 185-221
Molecular Diagnosis of Intestinal Amebiasis#
Among the four intestinal Entamoeba species, only E. histolytica causes disease and requires treatment regardless of symptomatic status. E. dispar is almost universally accepted as a non-pathogenic species. E. moshkovskii has been detected in both symptomatic and asymptomatic individuals. The pathogenicity of E. bangladeshi remains obscure as it has only been detected in very few individuals. Species-specific prevalence of different Entamoeba is not well understood as most studies still use methods that are non-specific. This chapter discusses the current methods used in the diagnosis of human intestinal amebiasis, and emphasizes the importance of molecular-based methods. Species-specific detection of Entamoeba species is not only important to understand the true epidemiology and pathogenicity of these amebae, but also for treatment decisions. Simple stool antigen-based detection methods (e.g., ELISAs) are still needed for E. dispar, E. moshkovskii, and E. bangladeshi. Similarly, simple DNA-based detection methods (e.g., LAMP assay) that can easily be implemented in resource-poor settings are needed. Molecular diagnostic tests capable of simultaneously detecting three or more of these Entamoeba species in clinical samples are still scarce. High-throughput sequence-based methods utilizing clinical samples (e.g., stools) is needed to identify novel species of Entamoeba.
- 13 November 2023
- Published by Taylor & Francis
- p. 185-221
Molecular Diagnosis of Intestinal Amebiasis#
Among the four intestinal Entamoeba species, only E. histolytica causes disease and requires treatment regardless of symptomatic status. E. dispar is almost universally accepted as a non-pathogenic species. E. moshkovskii has been detected in both symptomatic and asymptomatic individuals. The pathogenicity of E. bangladeshi remains obscure as it has only been detected in very few individuals. Species-specific prevalence of different Entamoeba is not well understood as most studies still use methods that are non-specific. This chapter discusses the current methods used in the diagnosis of human intestinal amebiasis, and emphasizes the importance of molecular-based methods. Species-specific detection of Entamoeba species is not only important to understand the true epidemiology and pathogenicity of these amebae, but also for treatment decisions. Simple stool antigen-based detection methods (e.g., ELISAs) are still needed for E. dispar, E. moshkovskii, and E. bangladeshi. Similarly, simple DNA-based detection methods (e.g., LAMP assay) that can easily be implemented in resource-poor settings are needed. Molecular diagnostic tests capable of simultaneously detecting three or more of these Entamoeba species in clinical samples are still scarce. High-throughput sequence-based methods utilizing clinical samples (e.g., stools) is needed to identify novel species of Entamoeba.
- 25 August 2021
- Published by American Society for Microbiology in mSphere
- Vol. 6 (4) , e0063721
Comparative Genomic and Transcriptomic Analysis of Naegleria fowleri Clinical and Environmental Isolates
N. fowleri , the only known Naegleria species to infect humans, causes fatal brain disease. PAM cases from 1965 to 2016 showed <20 cases per year globally.
- 25 August 2021
- Published by American Society for Microbiology in mSphere
- Vol. 6 (4) , e0063721
Comparative Genomic and Transcriptomic Analysis of Naegleria fowleri Clinical and Environmental Isolates
N. fowleri , the only known Naegleria species to infect humans, causes fatal brain disease. PAM cases from 1965 to 2016 showed <20 cases per year globally.
- 15 April 2021
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 10 (15)
Draft Chromosome Sequences of a Clinical Isolate of the Free-Living Ameba Naegleria fowleri
We present the chromosome sequences of a Naegleria fowleri isolate from a human primary amebic meningoencephalitis (PAM) case. The genome sequences were assembled from Illumina HiSeq and PacBio sequencing data and verified with the optical mapping data.
- 15 April 2021
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 10 (15)
Draft Chromosome Sequences of a Clinical Isolate of the Free-Living Ameba Naegleria fowleri
We present the chromosome sequences of a Naegleria fowleri isolate from a human primary amebic meningoencephalitis (PAM) case. The genome sequences were assembled from Illumina HiSeq and PacBio sequencing data and verified with the optical mapping data.
- 17 December 2020
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 59 (1)
A Real-Time PCR Assay for Simultaneous Detection and Differentiation of Four Common Entamoeba Species That Infect Humans
There are over 40 species within the genus Entamoeba , eight of which infect humans. Of these, four species ( Entamoeba histolytica , E. dispar , E. moshkovskii , and E. bangladeshi ) are morphologically indistinguishable from each other, and yet differentiation is important for appropriate treatment decisions. Here, we developed a hydrolysis probe-based tetraplex real-time PCR assay that can simultaneously detect and differentiate these four species in clinical samples.
- 17 December 2020
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 59 (1)
A Real-Time PCR Assay for Simultaneous Detection and Differentiation of Four Common Entamoeba Species That Infect Humans
There are over 40 species within the genus Entamoeba , eight of which infect humans. Of these, four species ( Entamoeba histolytica , E. dispar , E. moshkovskii , and E. bangladeshi ) are morphologically indistinguishable from each other, and yet differentiation is important for appropriate treatment decisions. Here, we developed a hydrolysis probe-based tetraplex real-time PCR assay that can simultaneously detect and differentiate these four species in clinical samples.
- 16 November 2019
- Published by Springer Nature in Parasitology Research
- Vol. 119 (1) , 339-344
A case of primary amebic meningoencephalitis caused by Naegleria fowleri in Bangladesh
We present the first recognized case of primary amebic meningoencephalitis (PAM) caused by Naegleria fowleri in a 15-year-old male from Bangladesh. He performed daily nasal rinsing with untreated ground water and bathed in untreated ground water or river water, which likely exposed him to N. fowleri.
- 16 November 2019
- Published by Springer Nature in Parasitology Research
- Vol. 119 (1) , 339-344
A case of primary amebic meningoencephalitis caused by Naegleria fowleri in Bangladesh
We present the first recognized case of primary amebic meningoencephalitis (PAM) caused by Naegleria fowleri in a 15-year-old male from Bangladesh. He performed daily nasal rinsing with untreated ground water and bathed in untreated ground water or river water, which likely exposed him to N. fowleri.
- 1 August 2018
- Published by Elsevier in Veterinary Parasitology: Regional Studies and Reports
- Vol. 13, 156-159
Canine amoebic meningoencephalitis due to Balamuthia mandrillaris
- 1 August 2018
- Published by Elsevier in Veterinary Parasitology: Regional Studies and Reports
- Vol. 13, 156-159
Canine amoebic meningoencephalitis due to Balamuthia mandrillaris
- 10 September 2016
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 18 (10) , 1-7
Primary Amebic Meningoencephalitis: What Have We Learned in the Last 5 Years?
Primary amebic meningoencephalitis (PAM) is a devastating infection of the brain caused by the thermophilic free-living ameba, Naegleria fowleri. Infection can occur when water containing the ameba enters the body through the nose, usually during recreational water activities such as swimming or diving. Historically, in the USA, cases were mostly reported from the warmer southern-tier states. In the last 5 years, several notable changes have been documented in PAM epidemiology including a northward expansion of infections and new types of water exposures. The recent reports of two PAM survivors provide hope for improved outcomes with early diagnosis and aggressive treatment. Advanced molecular laboratory tools such as genome sequencing might provide more insight into the pathogenicity of N. fowleri. Clinicians treating patients with meningitis and warm freshwater exposure are encouraged to consider PAM in their differential diagnoses.
- 10 September 2016
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 18 (10) , 1-7
Primary Amebic Meningoencephalitis: What Have We Learned in the Last 5 Years?
Primary amebic meningoencephalitis (PAM) is a devastating infection of the brain caused by the thermophilic free-living ameba, Naegleria fowleri. Infection can occur when water containing the ameba enters the body through the nose, usually during recreational water activities such as swimming or diving. Historically, in the USA, cases were mostly reported from the warmer southern-tier states. In the last 5 years, several notable changes have been documented in PAM epidemiology including a northward expansion of infections and new types of water exposures. The recent reports of two PAM survivors provide hope for improved outcomes with early diagnosis and aggressive treatment. Advanced molecular laboratory tools such as genome sequencing might provide more insight into the pathogenicity of N. fowleri. Clinicians treating patients with meningitis and warm freshwater exposure are encouraged to consider PAM in their differential diagnoses.